PharmiWeb.com - Global Pharma News & Resources
12-Sep-2024

HCP insights consultancy launches new platform for pharmaceutical industry to identify HCP sentiment and top digital opinion leaders in key disease spaces

A new platform has been launched this week which will allow the pharmaceutical industry to identify the most influential healthcare professionals discussing major diseases, treatments and trials on social media. 

 

DOL Finder, an unprecedented new database developed by leading digital insights consultancy Creation Healthcare, will allow users to identify, monitor, and understand the most influential online healthcare professionals - or eHCPs - in any given disease space, aimed at enabling pharmaceutical organizations to optimize their HCP engagement and marketing delivery.

 

The application’s launch was announced this week at the 60th Annual Meeting of the European Association for the Study of Diabetes (EASD), currently taking place in Madrid. Its introduction was accompanied by a demonstration of the platform’s functionality in its first indication, type 2 diabetes.

 

(Creation Healthcare launching their new app, DOL Finder, at the EASD 2024 Conference in Madrid alongside healthcare professionals. From Left: Domenica Carpio, Analyst, Creation Healthcare; Dr Amit Gupta, Chair Elect, Public Health and Epidemiology Interest Group, American Diabetes Association; Anni Neumann, Director of Health Strategy, Creation Healthcare; Dr Banshi Saboo, Chief Diabetologist & Chairman of Dia Care, Diabetes Care & Hormone Clinic)

 

The platform will offer users several tools. It will, for example, enable organizations to discover their Digital Opinion Leaders - or those who have the largest impact in spaces most relevant to each business. Users can filter through all HCPs talking online by specialty, country, date range, or the name of an individual healthcare professional.

 

Users will be able to identify the most influential HCPs on social media, ranked using Creation’s unique Impact Score. In just the type 2 diabetes space, DOL Finder’s dataset will draw on the online activity of more than 30,000 healthcare professionals. Their assessment measurements include analytics like social media activity, peer-to-peer trust and overall audience reach.

 

Though launched first with a focus on type 2 diabetes online conversations, Creation Healthcare anticipate the release of DOL Finder in any indication over the coming months. A pilot of the platform in the online breast cancer space is also expected to be made available to users in the next several weeks.

 

The platform will also offer users a unique opportunity to learn about each HCPs’ views and influence on a given subject area, for example on manufacturers, products, trials, and hashtags. Using Creation Healthcare’s sentiment analysis technology, users can dive into both individual and collective HCP perspectives on treatments and therapy areas at large.

 

The technology is drawn from expertise honed after more than two decades of experience in listening to the social media conversations of healthcare professionals. This is made possible through CREATION Pinpoint®, the world’s only AI-powered global database of more than 3 million healthcare professionals’ social media profiles, analyzing the collective intelligence of almost 2 billion social media posts by those on the front lines of healthcare.  

 

As part of Creation Healthcare's broader vision, this launch fulfills a long-held ambition to make valuable social media data more accessible - not only to clients, but to the wider pharmaceutical industry, in the interests of improving health outcomes.

 

“DOL Finder opens up access to Creation’s deep HCP social media intelligence platform, built over the past twelve years”, said Daniel Ghinn, Founder of Creation Healthcare, announcing the app’s launch. “For the first time, you can explore the data and identify the most impactful HCP Digital Opinion Leaders tailored to your needs and objectives. 

 

"We’ve always been asked when we would make our data directly available to clients, and it’s been a dream to get them closer to our insights”, Ghinn continued. “It’s now time to open up the depth of our analytical capacities to a wider pharmaceutical audience.”

 

DOL Finder  is one of two new products scheduled for release by Creation Healthcare over the coming months. Separately at the EASD Conference, they are offering attendees a chance to trial a second app, Pinpoint for Healthcare Professionals, which will hand social media data back to healthcare professionals themselvesThe platform, after incorporating HCP feedback through the conference, will offer professionals on the frontline the ability to measure and improve their own online impact among peers - in the interests of themselves, the wider healthcare community, and the public as a whole.

 

Editor Details

  • Name:
    • pharmiweb
Last Updated: 12-Sep-2024